E-LIB Suche - Ergebnisse für: Weitman, Steven

1

Safety, tolerability, and preliminary activity of IMGN529, ..:

Stathis, Anastasios ; Flinn, Ian W. ; Madan, Sumit...
Investigational New Drugs. 36 (2018) 5 - p. 869-876 , 2018

Link: https://doi.org/10.1007/..

2

Combined venetoclax and alvocidib in acute myeloid leukemia:

Bogenberger, James ; Whatcott, Clifford ; Hansen, Nanna...
Oncotarget. 8 (2017) 63 - p. 107206-107222 , 2017

Link: https://doi.org/10.18632..

3

Risks and benefits of phase I liver dysfunction studies: sh..:

Fountzilas, Christos ; Stuart, Selena ; Hernandez, Brian...
Investigational New Drugs. 35 (2017) 3 - p. 386-391 , 2017

Link: https://doi.org/10.1007/..

4

Phase 1 study evaluating the safety and pharmacokinetics of..:

Kelly, Kevin R. ; Gabrail, Nashat ; Weitman, Steven...
Cancer Chemotherapy and Pharmacology. 78 (2016) 5 - p. 929-939 , 2016

Link: https://doi.org/10.1007/..

5

The MCL-1 targeting effect of alvocidib potentiates the act..:

Kim, Wontak ; Bahr, Brigham L. ; Soh, Katherine K....
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. S18 , 2015

Link: https://doi.org/10.1016/..

6

Phase I study of intravenously administered ATI-1123, a lip..:

Mahalingam, Devalingam ; Nemunaitis, John J. ; Malik, Laeeq...
Cancer Chemotherapy and Pharmacology. 74 (2014) 6 - p. 1241-1250 , 2014

Link: https://doi.org/10.1007/..

7

Eligibility of patients with renal impairment for Phase I t..:

Malik, Laeeq ; Mejia, Alex ; Weitman, Steven
European Journal of Cancer. 50 (2014) 17 - p. 2893-2896 , 2014

Link: https://doi.org/10.1016/..

8

Predicting success in regulatory approval from Phase I resu..:

Malik, Laeeq ; Mejia, Alex ; Parsons, Helen...
Cancer Chemotherapy and Pharmacology. 74 (2014) 5 - p. 1099-1103 , 2014

Link: https://doi.org/10.1007/..

9

Single‐cell analysis of circulating tumor cells identifies ..:

Chen, Chun‐Liang ; Mahalingam, Devalingam ; Osmulski, Pawel...
The Prostate. 73 (2012) 8 - p. 813-826 , 2012

Link: https://doi.org/10.1002/..

10

The angiogenesis inhibitor NM-3 is active against human NSC..:

Agata, Naoki ; Nogi, Hiroko ; Bamberg, Michael...
Cancer Chemotherapy and Pharmacology. 56 (2005) 6 - p. 610-614 , 2005

Link: https://doi.org/10.1007/..

11

AMD473 (ZD0473) exhibits marked in vitro anticancer activit..:

Medina-Gundrum, Leticia ; Cerna, Cesario ; Gomez, Lionel R...
Anti-Cancer Drugs. 14 (2003) 4 - p. 275-280 , 2003

Link: https://doi.org/10.1097/..

12

Anemia and Hepatosplenomegaly as Presenting Features in a C..:

Gruner, Barbara A. ; DeNapoli, Thomas S. ; Elshihabi, Said...
Journal of Pediatric Hematology/Oncology. 25 (2003) 10 - p. 813-815 , 2003

Link: https://doi.org/10.1097/..

13

Antitumor activity of irofulven monotherapy and in combinat..:

Van Laar, Emily S. ; Weitman, Steven ; MacDonald, John R..
The Prostate. 59 (2003) 1 - p. 22-32 , 2003

Link: https://doi.org/10.1002/..

14

Phase I Trial of Rebeccamycin Analog (NSC #655649) in Child..:

Langevin, Anne-Marie ; Weitman, Steven D. ; Kuhn, John G....
Journal of Pediatric Hematology/Oncology. 25 (2003) 7 - p. 526-533 , 2003

Link: https://doi.org/10.1097/..

15

Direct Raman imaging techniques for study of the subcellula..:

Ling, Jian ; Weitman, Steven D. ; Miller, Michael A...
Applied Optics. 41 (2002) 28 - p. 6006 , 2002

Link: https://doi.org/10.1364/..